Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Significant efficacy and well safety of apatinib in an advanced liver cancer patient: a case report and literature review

Published:2017-01-18 Issue:12 Volume:8 Page:20510-20515
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kou Peisi¹²,Zhang Yan²,Shao Wenbo³,Zhu Hui²,Zhang Jingze²,Wang Haiyong²,Kong Li²,Yu Jinming²⁴¹

Affiliation:

1. Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

2. Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China

3. Department of Intervention, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China

4. School of Medicine and Life Sciences, University of Jinan - Shandong Academy of Medical Sciences, Jinan, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Study on Long-acting Nanobubbles: Current Advancement and Prospects on Theranostic Properties;Advanced Pharmaceutical Bulletin;2024-03-17

2. Integrative analysis of multi-omics data reveals inhibition of RB1 signaling promotes apatinib resistance of hepatocellular carcinoma;International Journal of Biological Sciences;2023

3. The Prognostic Role of VEGFR-2 Gene Amplification in Relation to Serum AFP Levels Among Liver-Transplanted Patients with Hepatocellular Carcinoma;Journal of Current Oncology;2022-12

4. Successful apatinib treatment for advanced clear cell renal carcinoma as a first-line palliative treatment: A case report;World Journal of Clinical Cases;2022-04-16

5. The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis;World Journal of Surgical Oncology;2022-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3